What is the first step in managing Gestational Diabetes Mellitus (GDM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Management of Gestational Diabetes Mellitus (GDM)

The first step in managing Gestational Diabetes Mellitus (GDM) should be lifestyle modifications, including individualized medical nutrition therapy and regular physical activity, as 70-85% of women diagnosed with GDM can achieve glycemic control through these interventions alone. 1, 2

Initial Approach to GDM Management

Medical Nutrition Therapy

  • An individualized nutrition plan should be developed between the patient and a registered dietitian nutritionist (RDN) familiar with GDM management 1, 2
  • The nutrition plan should provide:
    • Minimum 175g of carbohydrates daily (35% of a 2,000-calorie diet) 1
    • Minimum 71g of protein daily 1
    • 28g of fiber daily 1
    • Emphasis on monounsaturated and polyunsaturated fats while limiting saturated fats and avoiding trans fats 1
  • The plan should promote appropriate gestational weight gain according to the 2009 National Academy of Medicine recommendations 1
  • Focus should be placed on the type, amount, and distribution of carbohydrates to limit postprandial glucose excursions 3

Physical Activity

  • Regular moderate-intensity exercise is recommended for women with GDM 1
  • At least 150 minutes of moderate-intensity aerobic activity weekly, preferably spread throughout the week 1, 2
  • Exercise has been shown to improve glucose outcomes and reduce insulin requirements 1
  • Various types of exercise can be effective (aerobic, resistance, or both) with duration of 20-50 minutes per day, 2-7 days per week 1

Blood Glucose Monitoring and Targets

  • Self-monitoring of blood glucose should be initiated with the following targets 1, 2:
    • Fasting glucose < 95 mg/dL (5.3 mmol/L)
    • One-hour postprandial glucose < 140 mg/dL (7.8 mmol/L) or
    • Two-hour postprandial glucose < 120 mg/dL (6.7 mmol/L)
  • Regular monitoring is essential to assess the effectiveness of lifestyle interventions 2

When to Consider Pharmacological Therapy

  • If glycemic targets cannot be achieved with lifestyle modifications alone, pharmacological therapy should be considered 4, 5
  • Insulin is the first-line pharmacological agent recommended for GDM treatment in the United States 1, 2
  • Metformin and glyburide are not recommended as first-line treatments because they cross the placenta and have safety concerns for offspring 1

Common Pitfalls and Considerations

  • Delaying pharmacological therapy when lifestyle modifications are insufficient to achieve glycemic targets 2
  • Inadequate monitoring of blood glucose levels to assess treatment effectiveness 2
  • Women with greater initial degrees of hyperglycemia may require earlier initiation of pharmacological therapy 2
  • Failure to provide adequate caloric intake, which is necessary for fetal development 1

Long-term Considerations

  • Women with GDM have an increased risk of developing type 2 diabetes later in life 4, 5
  • Continued lifestyle modifications post-pregnancy can reduce this risk 4, 5
  • Breastfeeding should be encouraged as it may help reduce the risk of subsequent diabetes 4

By implementing appropriate lifestyle modifications as the first step in GDM management, the majority of women can achieve adequate glycemic control without medication, leading to improved maternal and fetal outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Treatment for Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Gestational Diabetes Mellitus.

Advances in experimental medicine and biology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.